slides · global inventory
11 Golden Circle
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,983
Current window 9,181-9,210
Pages 467
Rows per page 30
Loop
9,181-9,210 of 13,983
09
The diagram uses a clover-like circular arrangement to represent interconnected strategic pillars.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
10
The slide uses a hub-and-spoke style layout to connect a central commercial goal to specific strategic pillars.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
11
The slide uses a hub-and-spoke visual metaphor to connect the clinical class to the list of autoantibodies.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
12
The slide uses a pyramid-like structure to display patient population sizes for different medical conditions.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
13
The slide uses a timeline structure to map clinical development stages against specific disease indications and their associated U.S. patient prevalence numbers.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
14
The slide highlights the mechanism of action (sweeping antibody) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
15
Includes immunofluorescence microscopy images and bar charts/traces showing physiological recovery.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
16
Includes a biological mechanism diagram on the left and a clinical trial timeline/roadmap on the right.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
17
The slide uses a circular, overlapping design to categorize medical indications by therapeutic area.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
18
The slide uses a network-like background to visually connect the logos, implying a collaborative ecosystem.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
19
argenx SE | Investor Presentation Deck | 22 slidesargenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
20
The slide uses a hub-and-spoke diagram to center the company brand around its core values.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
21
The chart uses color-coding to represent therapeutic areas: Neurology (light green), Hematology and Rheumatology (light blue), Dermatology (dark blue), and Nephrology (dark green).argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
12
The slide uses a horizontal process-like layout to show AI application across the value chain.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
13
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
14
The slide uses a navigation bar at the top to indicate the current section (Oncology).AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
03
The slide uses a numbered list to present five key pillars of the company's value proposition.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a hierarchical structure to connect a high-level objective to three specific strategic pillars.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
The slide uses a Gantt-style visualization to show drug development progress.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses a timeline format to communicate both past achievements and future R&D milestones.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
ATAI | Investor Presentation Deck | 30 slidesATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Loop · Golden Circle1 hit
08
Uses a timeline-style vertical flow to represent the 'need' metrics.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
Includes a quote from Keith Nuechterlein, Ph.D. regarding the clinical significance of the Symbol Coding results.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a vertical process flow to show the progression of clinical trials and data validation.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
11
The slide highlights the 'inverted-U' dose-response curve, a key pharmacological characteristic for this drug candidate.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
12
The slide highlights that lower doses of RL-007 (40 or 80 mg TID) show statistically significant improvements compared to placebo in cognitive endpoints.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
13
The slide uses a standard clinical trial flow diagram to illustrate the study methodology.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
14
ATAI | Investor Presentation Deck | 30 slidesATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
15
The slide uses a split-layout: left side defines the condition and market size, right side highlights the 'unaddressed need' (treatment gap, comorbidity, and lack of innovation).ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
16
The slide uses a split-layout with a left-hand summary table and a right-hand clinical data visualization.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit